Serpil Erzurum

In this episode, Serpil Erzurum, MD, draws on her vast experience at health care systems across the country to discuss the importance of compassion as a mentor and trainee when paving the path for others, breaking the cycle of self-doubt and learning from disappointment and failure in our careers.  Intro :01 The interview :18 Who is Dr. Erzurum as a person? Passions, interests and childhood 1:13 What have been your favorite parts of working in health care across the country? 5:22 How do you juggle and find balance between the many different roles in health care? 9:53 The importance of enjoying life above all 11:50 Erzurum on surrounding yourself with people that respect your life choices 15:00 Paving the path for others; being a good mentor and leader 16:35 Erzurum on trusting and communicating with your mentors 20:00 Working through ‘imposter syndrome’; dealing with failure and self-doubt 21:45 Times when Dr. Erzurum faced disappointment and failure. 25:32 What do you do for fun? 28:15 Have you inspired your daughters? 30:12 Why don’t we expose specialists and trainees to specialties outside their own institutions? 31:44 What skillsets should trainees work to improve during Fellowship? 36:02 Final thoughts 39:15 Outro 41:18  Serpil Erzurum, MD, is the chief research and academic officer at the Cleveland Clinic. She is also the chair of Lerner Research Institute. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99. Disclosures: Bhardwaj and Erzurum report no relevant financial disclosures.

In this episode, Serpil Erzurum, MD, draws on her vast experience at health care systems across the country to discuss the importance of compassion as a mentor and trainee when paving the path for others, breaking the cycle of self-doubt and learning from disappointment and failure in our careers. <ul> <li>Intro :01</li> <li>The interview :18</li> <li>Who is Dr. Erzurum as a person? Passions, interests and childhood 1:13</li> <li>What have been your favorite parts of working in health care across the country? 5:22</li> <li>How do you juggle and find balance between the many different roles in health care? 9:53</li> <li>The importance of enjoying life above all 11:50</li> <li>Erzurum on surrounding yourself with people that respect your life choices 15:00</li> <li>Paving the path for others; being a good mentor and leader 16:35</li> <li>Erzurum on trusting and communicating with your mentors 20:00</li> <li>Working through ‘imposter syndrome’; dealing with failure and self-doubt 21:45</li> <li>Times when Dr. Erzurum faced disappointment and failure. 25:32</li> <li>What do you do for fun? 28:15</li> <li>Have you inspired your daughters? 30:12</li> <li>Why don’t we expose specialists and trainees to specialties outside their own institutions? 31:44</li> <li>What skillsets should trainees work to improve during Fellowship? 36:02</li> <li>Final thoughts 39:15</li> <li>Outro 41:18</li> </ul> Serpil Erzurum, MD, is the chief research and academic officer at the Cleveland Clinic. She is also the chair of Lerner Research Institute. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter <a href="https://twitter.com/HealioPulm" rel="nofollow" target="_blank">@HealioPulm</a> <a href="https://twitter.com/abhi_bhardwaj99" rel="nofollow" target="_blank">@abhi_bhardwaj99</a>. Disclosures: Bhardwaj and Erzurum report no relevant financial disclosures.

Mentorship and Compassion with Serpil Erzurum, MD 

We all will be at the receiving end of critical illness for ourselves or our loved ones. It is almost guaranteed. A family’s needs are the blind spot of the overstretched and dysfunctional health care system that needs to be addressed. Here, Kristin Flanary, also known as Lady Glaucomflecken, shares her experience, hoping to highlight the challenges of the families who are at the revived end of critical illness for their loved one. Take-home lessons for health care professionals: While clinical excellence and focus on the patient is an absolute given, what sets a great HCP apart is clear and frequent communication, empathy and kindness. Let’s do better.   Intro :00 The interview :39 Tell me a bit about yourself. Where did you grow up? What was life like before and now? 3:40 Having to do CPR on your loved one 13:01 Can you share with me what exactly happened when your husband went into cardiac arrest? And what can we do better? 20:47 The experience of being in the hospital 28:42 How did you manage being kicked out of the hospital? How long was he in the ICU and in the hospital for? 47:25 The struggle starts for patients and families when they come home because now they don't have the same support system. Can you share some of those struggles? 55:10 We are almost 21 months out from the cardiac arrest at this point. How are you both doing now? 1:02:14 Spreading the message about sudden cardiac arrest and learning to do bystander CPR. 1:05:32 Can you share a happy moment or memory since the cardiac arrest event? 1:11:15 Flanary’s message to listeners 1:16:15 Thank you, Kristin Flanary 1:18:32  Kristin Flanary, MA, is administrator and communications manager at Belin-Blank Center for Gifted Education &amp; Talent Development at the University of Iowa. To read Flanary’s article in Journal of Cardiac Failure, click here:  https://www.onlinejcf.com/action/showPdf?pii=S1071-9164%2821%2900403-6. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99. You can follow Kristin Flanary on Twitter @LGlaucomflecken. Disclosures: Bhardwaj and Flanary report no relevant financial disclosures. 

We all will be at the receiving end of critical illness for ourselves or our loved ones. It is almost guaranteed. A family’s needs are the blind spot of the overstretched and dysfunctional health care system that needs to be addressed. Here, Kristin Flanary, also known as Lady Glaucomflecken, shares her experience, hoping to highlight the challenges of the families who are at the revived end of critical illness for their loved one. Take-home lessons for health care professionals: While clinical excellence and focus on the patient is an absolute given, what sets a great HCP apart is clear and frequent communication, empathy and kindness. Let’s do better. <ul> <li>Intro :00</li> <li>The interview :39</li> <li>Tell me a bit about yourself. Where did you grow up? What was life like before and now? 3:40</li> <li>Having to do CPR on your loved one 13:01</li> <li>Can you share with me what exactly happened when your husband went into cardiac arrest? And what can we do better? 20:47</li> <li>The experience of being in the hospital 28:42</li> <li>How did you manage being kicked out of the hospital? How long was he in the ICU and in the hospital for? 47:25</li> <li>The struggle starts for patients and families when they come home because now they don't have the same support system. Can you share some of those struggles? 55:10</li> <li>We are almost 21 months out from the cardiac arrest at this point. How are you both doing now? 1:02:14</li> <li>Spreading the message about sudden cardiac arrest and learning to do bystander CPR. 1:05:32</li> <li>Can you share a happy moment or memory since the cardiac arrest event? 1:11:15</li> <li>Flanary’s message to listeners 1:16:15</li> <li>Thank you, Kristin Flanary 1:18:32</li> </ul> Kristin Flanary, MA, is administrator and communications manager at Belin-Blank Center for Gifted Education &amp; Talent Development at the University of Iowa. To read Flanary’s article in Journal of Cardiac Failure, click here: <a href="https://www.onlinejcf.com/action/showPdf?pii=S1071-9164%2821%2900403-6" rel="nofollow" target="_blank"> https://www.onlinejcf.com/action/showPdf?pii=S1071-9164%2821%2900403-6</a>. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter <a href="https://twitter.com/HealioPulm" rel="nofollow" target="_blank">@HealioPulm</a> <a href="https://twitter.com/abhi_bhardwaj99" rel="nofollow" target="_blank">@abhi_bhardwaj99</a>. You can follow Kristin Flanary on Twitter <a href="https://twitter.com/LGlaucomflecken" rel="nofollow" target="_blank">@LGlaucomflecken</a>. Disclosures: Bhardwaj and Flanary report no relevant financial disclosures.

Critical Illness Cosurvivors: An Interview with Lady Glaucomflecken

Holding onto Hope During a Pandemic with Hassan Khouli, MD

Kristin Highland

Kristin B. Highland, MS, MD, does it all and makes it look easy. In this episode, we discuss how to follow your dreams, balance your life and define success on your own terms.  Intro :01 About Highland :16 The interview :33 At Cleveland Clinic, we don't care about your birth coordinates. We care about who you are and what you bring to the table. :54 Imposter syndrome 3:15 Tell me a bit about your background, your personal life, your professional life. Where did your journey start? 7:48 The nonlinear journey to success 30:48 The end of fellowship is not the end of your expertise 37:11 Balancing work and family as a single mother 39:38 Best advice to be a good mentee 45:43 What other skill sets should fellows acquire during training beyond clinical excellence? 46:51 Thank you, Dr. Highland 51:41  Kristin B. Highland, MS, MD, is fellowship trained in both pulmonary/critical care and rheumatology and is the respiratory institute research officer and associate program director for research and scholarship at the Cleveland Clinic. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99.

Kristin B. Highland, MS, MD, does it all and makes it look easy. In this episode, we discuss how to follow your dreams, balance your life and define success on your own terms. <ul> <li>Intro :01</li> <li>About Highland :16</li> <li>The interview :33</li> <li>At Cleveland Clinic, we don't care about your birth coordinates. We care about who you are and what you bring to the table. :54</li> <li>Imposter syndrome 3:15</li> <li>Tell me a bit about your background, your personal life, your professional life. Where did your journey start? 7:48</li> <li>The nonlinear journey to success 30:48</li> <li>The end of fellowship is not the end of your expertise 37:11</li> <li>Balancing work and family as a single mother 39:38</li> <li>Best advice to be a good mentee 45:43</li> <li>What other skill sets should fellows acquire during training beyond clinical excellence? 46:51</li> <li>Thank you, Dr. Highland 51:41</li> </ul> Kristin B. Highland, MS, MD, is fellowship trained in both pulmonary/critical care and rheumatology and is the respiratory institute research officer and associate program director for research and scholarship at the Cleveland Clinic. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter <a href="https://twitter.com/HealioPulm" rel="nofollow" target="_blank">@HealioPulm</a> <a href="https://twitter.com/abhi_bhardwaj99" rel="nofollow" target="_blank">@abhi_bhardwaj99</a>.

Leadership, Research and Patient Care with Kristin Highland, MD

In this episode, E. Wes Ely, MD, MPH, discusses the value of human connection with patients, reflects on the values of hope and mercy in patient care, and reads key excerpts from his book, Every Deep-Drawn Breath.  Intro :01 About Ely :21 About Every Deep-Drawn Breath :49 The interview 1:20 Impact of Ely’s work 1:37 Tell me a bit about your background. Where did this all start? 5:32 Do you think if you spend enough time and cater deeply enough, you can create that human connection? 9:24 The other side of the bed 15:00 The story of Jimmy Johnson 29:49 Bringing back normalcy in the ICU for patient healing 35:11 How do you bring hope during this dark period? 40:20 Spirituality in patient care 44:57 Significance of Every Deep-Drawn Breath 51:03 Thank you, Dr. Ely 53:50  Wes Ely, MD, MPH, is professor of medicine and critical care at Vanderbilt University Medical Center and associate director of aging research at VA Tennessee Valley Geriatric Research and Education Clinical Center. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99. You can reach Dr. Ely on Twitter  @WesElyMD. Disclosures: Bhardwaj reports no relevant financial disclosures. Ely is author of Every Deep-Drawn Breath.

In this episode, E. Wes Ely, MD, MPH, discusses the value of human connection with patients, reflects on the values of hope and mercy in patient care, and reads key excerpts from his book, Every Deep-Drawn Breath. <ul> <li>Intro :01</li> <li>About Ely :21</li> <li>About Every Deep-Drawn Breath :49</li> <li>The interview 1:20</li> <li>Impact of Ely’s work 1:37</li> <li>Tell me a bit about your background. Where did this all start? 5:32</li> <li>Do you think if you spend enough time and cater deeply enough, you can create that human connection? 9:24</li> <li>The other side of the bed 15:00</li> <li>The story of Jimmy Johnson 29:49</li> <li>Bringing back normalcy in the ICU for patient healing 35:11</li> <li>How do you bring hope during this dark period? 40:20</li> <li>Spirituality in patient care 44:57</li> <li>Significance of Every Deep-Drawn Breath 51:03</li> <li>Thank you, Dr. Ely 53:50</li> </ul> Wes Ely, MD, MPH, is professor of medicine and critical care at Vanderbilt University Medical Center and associate director of aging research at VA Tennessee Valley Geriatric Research and Education Clinical Center. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter <a href="https://twitter.com/HealioPulm" rel="nofollow" target="_blank">@HealioPulm</a> <a href="https://twitter.com/abhi_bhardwaj99" rel="nofollow" target="_blank">@abhi_bhardwaj99</a>. You can reach Dr. Ely on Twitter <a href="https://twitter.com/WesElyMD?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor" rel="nofollow" target="_blank"> @WesElyMD</a>. Disclosures: Bhardwaj reports no relevant financial disclosures. Ely is author of Every Deep-Drawn Breath.

Every Deep-Drawn Breath with E. Wes Ely, MD, MPH

In this episode, Bhardwaj’s mentor, Benjamin S. Abella, MD, MPhil, FACEP, FAHA, discusses the importance of a strong mentor-mentee relationship, his path into internal and emergency medicine training and much more.    Intro :00 Welcome to another episode of Vital Capacity :19 About Abella :28 The interview 1:40 Tell me a bit about yourself in your own words 1:54 The importance of blending the personal and professional aspects of academic mentorship 5:00 How do you find balance? Define a day for me 8:41 You’re one of the few people in the country who are trained in both internal medicine and emergency medicine … Can you share with me how that started? 11:50 If someone wants to have a physician-scientist career, what advice would you give them and do you have any experiences and examples you can share? 18:21 After you were trained in emergency medicine residency and the resuscitation fellowship, you are now leading all these efforts at Penn. When did that transition happen? 21:14 Can you share some of the ways you navigate talking to other physicians and convey the message of timing of cardiac care after cardiac arrest? 29:11 Can you tell us the story about the soldier and the use of cardiac cooling? 34:53 Thanks so much, Ben 39:33  Benjamin S. Abella, MD, MPhil, FACEP, FAHA, is the professor and vice chair of research at University of Pennsylvania’s Department of Emergency Medicine. He directs the Center for Resuscitation Science and the Penn Acute Research Collaboration at the University. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99. You can reach Abella on Twitter @benjaminabella. Disclosures: Abella reports receiving honoraria from Becton Dickinson, Stryker and Zoll; research fees from Becton Dickinson, NIH and PCORI; and ownership in MD Ally and VOC Health. Bhardwaj reports no relevant financial disclosures.

In this episode, Bhardwaj’s mentor, Benjamin S. Abella, MD, MPhil, FACEP, FAHA, discusses the importance of a strong mentor-mentee relationship, his path into internal and emergency medicine training and much more.   <ul> <li>Intro :00</li> <li>Welcome to another episode of Vital Capacity :19</li> <li>About Abella :28</li> <li>The interview 1:40</li> <li>Tell me a bit about yourself in your own words 1:54</li> <li>The importance of blending the personal and professional aspects of academic mentorship 5:00</li> <li>How do you find balance? Define a day for me 8:41</li> <li>You’re one of the few people in the country who are trained in both internal medicine and emergency medicine … Can you share with me how that started? 11:50</li> <li>If someone wants to have a physician-scientist career, what advice would you give them and do you have any experiences and examples you can share? 18:21</li> <li>After you were trained in emergency medicine residency and the resuscitation fellowship, you are now leading all these efforts at Penn. When did that transition happen? 21:14</li> <li>Can you share some of the ways you navigate talking to other physicians and convey the message of timing of cardiac care after cardiac arrest? 29:11</li> <li>Can you tell us the story about the soldier and the use of cardiac cooling? 34:53</li> <li>Thanks so much, Ben 39:33</li> </ul> Benjamin S. Abella, MD, MPhil, FACEP, FAHA, is the professor and vice chair of research at University of Pennsylvania’s Department of Emergency Medicine. He directs the Center for Resuscitation Science and the Penn Acute Research Collaboration at the University. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter <a href="https://twitter.com/HealioPulm" rel="nofollow" target="_blank">@HealioPulm</a> <a href="https://twitter.com/abhi_bhardwaj99" rel="nofollow" target="_blank">@abhi_bhardwaj99</a>. You can reach Abella on Twitter <a href="https://twitter.com/benjaminabella" rel="nofollow" target="_blank">@benjaminabella</a>. Disclosures: Abella reports receiving honoraria from Becton Dickinson, Stryker and Zoll; research fees from Becton Dickinson, NIH and PCORI; and ownership in MD Ally and VOC Health. Bhardwaj reports no relevant financial disclosures.

Mentorship and Career in Academic Medicine with Benjamin S. Abella, MD, MPhil

This week, FDA advisory committee unanimously recommends Moderna booster shot; the USPSTF advises against aspirin for primary CVD prevention for adults 60 years or older; FDA permits marketing of new e-cigarette products; and more. Read the full coverage here:  FDA advisory committee unanimously recommends Moderna booster shot  USPSTF advises against aspirin for primary CVD prevention for adults 60 years or older  FDA permits marketing of new e-cigarette products, marking first authorization of its kind  More than half of COVID-19 survivors experience symptoms 6 months after recovery  FDA issues new guidance on sodium, calls it ‘pivotal’ moment in US health References:  FDA Press Release  USPSTF Statement  Press Release Groff D, et al. JAMA Network Open. 2021;doi:10.1001/jamanetworkopen.2021.28568. FDA Conference Call

This week, FDA advisory committee unanimously recommends Moderna booster shot; the USPSTF advises against aspirin for primary CVD prevention for adults 60 years or older; FDA permits marketing of new e-cigarette products; and more. Read the full coverage here: <a href="https://www.healio.com/news/infectious-disease/20211014/fda-advisory-committee-unanimously-recommends-moderna-booster-shot" rel="nofollow" target="_blank"> FDA advisory committee unanimously recommends Moderna booster shot</a> <a href="https://www.healio.com/news/cardiology/20211012/uspstf-advises-against-aspirin-for-primary-cvd-prevention-for-adults-60-years-or-older" rel="nofollow" target="_blank"> USPSTF advises against aspirin for primary CVD prevention for adults 60 years or older</a> <a href="https://www.healio.com/news/pulmonology/20211013/fda-permits-marketing-of-new-ecigarette-products-marking-first-authorization-of-its-kind" rel="nofollow" target="_blank"> FDA permits marketing of new e-cigarette products, marking first authorization of its kind</a> <a href="https://www.healio.com/news/infectious-disease/20211014/more-than-half-of-covid19-survivors-experience-symptoms-6-months-after-recovery" rel="nofollow" target="_blank"> More than half of COVID-19 survivors experience symptoms 6 months after recovery</a> <a href="https://www.healio.com/news/primary-care/20211013/fda-issues-new-guidance-on-sodium-calls-it-pivotal-moment-in-us-health" rel="nofollow" target="_blank"> FDA issues new guidance on sodium, calls it ‘pivotal’ moment in US health</a> References: <a href="https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-october-14-15-2021-meeting-announcement" rel="nofollow" target="_blank"> FDA Press Release</a> <a href="https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication" rel="nofollow" target="_blank"> USPSTF Statement</a> <a href="https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-e-cigarette-products-marking-first-authorization-its-kind-agency?utm_medium=email&amp;utm_source=govdelivery" rel="nofollow" target="_blank"> Press Release</a> Groff D, et al. JAMA Network Open. 2021;doi:10.1001/jamanetworkopen.2021.28568. FDA Conference Call

Top news this week: FDA advisory committee unanimously recommends Moderna booster shot

This week, use of systemic corticosteroids is linked with worse covid-19 outcomes; an investigational antiviral drug reduces risk for hospitalization and death by about 50% in patients with COVID-19; Pfizer-BioNTech submit vaccine data for children aged 5 to 11 to FDA; and more. Read the full coverage here:  Use of systemic corticosteroids linked with worse COVID-19 outcomes  Antiviral reduces risk for hospitalization, death by about 50% in patients with COVID-19  Pfizer-BioNTech submit vaccine data for children aged 5 to 11 to FDA  Unlike flu, cold viruses persisted during pandemic, study finds  AstraZeneca COVID-19 vaccine 74% effective, protects against asymptomatic disease References: Yochai A, et al. Asthma treatment: clinical and translational science. Presented at: European Respiratory Society International Congress; Sept. 5-8, 2021 (virtual meeting). Press Release Press Release Rankin, DA, et al. Abstract 154. Presented at: IDWeek; Sept. 29-Oct. 3, 2021 (virtual meeting). Sobieszczyk M, et al. Abstract LB6. Presented at: IDWeek; Sept. 29-Oct. 3, 2021 (virtual meeting).

This week, use of systemic corticosteroids is linked with worse covid-19 outcomes; an investigational antiviral drug reduces risk for hospitalization and death by about 50% in patients with COVID-19; Pfizer-BioNTech submit vaccine data for children aged 5 to 11 to FDA; and more. Read the full coverage here: <a href="https://www.healio.com/news/pulmonology/20210927/use-of-systemic-corticosteroids-linked-with-worse-covid19-outcomes" rel="nofollow" target="_blank"> Use of systemic corticosteroids linked with worse COVID-19 outcomes</a> <a href="https://www.healio.com/news/primary-care/20211001/antiviral-reduces-risk-for-hospitalization-death-by-about-50-in-patients-with-covid19" rel="nofollow" target="_blank"> Antiviral reduces risk for hospitalization, death by about 50% in patients with COVID-19</a> <a href="https://www.healio.com/news/primary-care/20210928/pfizer-biontech-submit-initial-results-vaccine-dataon-for-children-aged-5-to-11-2to-fda" rel="nofollow" target="_blank"> Pfizer-BioNTech submit vaccine data for children aged 5 to 11 to FDA</a> <a href="https://www.healio.com/news/primary-care/20210930/unlike-flu-cold-viruses-persisted-during-pandemic-study-finds" rel="nofollow" target="_blank"> Unlike flu, cold viruses persisted during pandemic, study finds</a> <a href="https://www.healio.com/news/primary-care/20211001/astrazeneca-covid19-vaccine-74-effective-protects-against-asymptomatic-disease" rel="nofollow" target="_blank"> AstraZeneca COVID-19 vaccine 74% effective, protects against asymptomatic disease</a> References: Yochai A, et al. Asthma treatment: clinical and translational science. Presented at: European Respiratory Society International Congress; Sept. 5-8, 2021 (virtual meeting). Press Release Press Release Rankin, DA, et al. Abstract 154. Presented at: IDWeek; Sept. 29-Oct. 3, 2021 (virtual meeting). Sobieszczyk M, et al. Abstract LB6. Presented at: IDWeek; Sept. 29-Oct. 3, 2021 (virtual meeting).

Top news this week: Systemic corticosteroids linked with worse COVID-19 outcomes

Eduardo Mireles-Cabodevila, MD, is an internationally renowned "Guru of Mechanical Ventilation and Neuromuscular Disease." He is also a fearless leader in the ICU. In this episode, he shares his journey into medicine and how he developed the “10 commandments” of fellowship research.  Intro :00 Mireles, thank you for joining me today :19 The interview 1:07 In your own words, tell me about your journey … How did this start? 1:13 How many years is med school in Mexico? 4:45 And you did internal medicine residency after that? 5:43 So, you did you 2 years of training there and then moved to the U.S.? 6:36 I have heard that you had tried to call the secretary back in the day at the Cleveland Clinic and you were not getting to the person … and then eventually you became the boss of the same secretary. 9:43 You just briefly touched on the value that your wife played in your life. Can you tell me a little bit more about your family? 11:23 Were the initial few years hard in the U.S.? 12:40 What other challenges did you navigate? 15:03 How did you become so fearless? 18:26 How did you get into these different roles? 23:29 Tell me a little bit about how, after almost a decade of this leadership position that you have, how do you prevent burnout? 32:13 Where are some of the favorite places you have traveled? 37:43 Do you read a lot apart from the books that you need to double up your expertise beyond what everyone does? 39:53 You’re known as the “ventilator guru,” and that’s how you’re educating the world, not just the Cleveland Clinic. How did you get better at it? 41:45 I remember being told a story that you were working on a research project, and you didn’t find anything meaningful there and you turned that disappointment into the 10 commandments. Can you share with me what that was? 46:25 What’s your most important advice to the listener? 49:38 Thank you so much for your time, Dr. Mireles 50:23  Eduardo Mireles-Cabodevila, MD, is the director of the Medical Intensive Care Unit and medical director of the Simulation and Advanced Skills Center at the Cleveland Clinic. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99. Disclosures: Bhardwaj and Mireles-Cabodevila report no relevant financial disclosures.

Eduardo Mireles-Cabodevila, MD, is an internationally renowned "Guru of Mechanical Ventilation and Neuromuscular Disease." He is also a fearless leader in the ICU. In this episode, he shares his journey into medicine and how he developed the “10 commandments” of fellowship research. <ul> <li>Intro :00</li> <li>Mireles, thank you for joining me today :19</li> <li>The interview 1:07</li> <li>In your own words, tell me about your journey … How did this start? 1:13</li> <li>How many years is med school in Mexico? 4:45</li> <li>And you did internal medicine residency after that? 5:43</li> <li>So, you did you 2 years of training there and then moved to the U.S.? 6:36</li> <li>I have heard that you had tried to call the secretary back in the day at the Cleveland Clinic and you were not getting to the person … and then eventually you became the boss of the same secretary. 9:43</li> <li>You just briefly touched on the value that your wife played in your life. Can you tell me a little bit more about your family? 11:23</li> <li>Were the initial few years hard in the U.S.? 12:40</li> <li>What other challenges did you navigate? 15:03</li> <li>How did you become so fearless? 18:26</li> <li>How did you get into these different roles? 23:29</li> <li>Tell me a little bit about how, after almost a decade of this leadership position that you have, how do you prevent burnout? 32:13</li> <li>Where are some of the favorite places you have traveled? 37:43</li> <li>Do you read a lot apart from the books that you need to double up your expertise beyond what everyone does? 39:53</li> <li>You’re known as the “ventilator guru,” and that’s how you’re educating the world, not just the Cleveland Clinic. How did you get better at it? 41:45</li> <li>I remember being told a story that you were working on a research project, and you didn’t find anything meaningful there and you turned that disappointment into the 10 commandments. Can you share with me what that was? 46:25</li> <li>What’s your most important advice to the listener? 49:38</li> <li>Thank you so much for your time, Dr. Mireles 50:23</li> </ul> Eduardo Mireles-Cabodevila, MD, is the director of the Medical Intensive Care Unit and medical director of the Simulation and Advanced Skills Center at the Cleveland Clinic. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter <a href="https://twitter.com/HealioPulm" rel="nofollow" target="_blank">@HealioPulm</a> <a href="https://twitter.com/abhi_bhardwaj99" rel="nofollow" target="_blank">@abhi_bhardwaj99</a>. Disclosures: Bhardwaj and Mireles-Cabodevila report no relevant financial disclosures.

Medical Education and Leadership, Part 6: Foreign Medical Grads in Leadership with Eduardo Mireles-Cabodevila MD

In this episode, Atul C. Mehta, MB, BS, discusses his path to become a physician, his early struggles once he arrived in the United States and some of the changes he’s witnessed in how bronchoscopies are performed.  Intro :00 About Mehta :23 The interview 1:25 In your own words … how did you get into medicine? 2:14 Can you share a little bit about your initial struggle coming to the United States? 7:10 Is your altruistic nature as a physician and mentor a result of coming from a humble background when you started your medical career? 13:14 You still work 15, 16 hours a day for almost 50 years … How do you have the energy to do that? 17:10 What have you seen that has changed from when you saw your first flexible bronchoscopy to now? 20:07 How do you find time for family with all you do and how do you do justice with that? 24:53 How do you prevent burnout in this demanding career? 28:21 You have worked in different countries … how did those things happen? 33:15 How old were your kids during your time working in India and Abu Dhabi? 37:01 I know you have family in Bollywood … are you a big fan of Bollywood? 39:42 Do you have a moment to share any failures that you felt were really important to learn from? 40:30 Do you have very fond memories from your childhood, or any med school quotes that you think of? 43:37 Is there anything else you’d like to share? 45:40 Thanks for listening! 45:49  Atul C. Mehta, MB, BS, is professor of medicine, Lerner College of Medicine; endowed chair in lung transplantation, Cleveland Clinic and founder and president of the American Association of Bronchoscopy. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99. Disclosures: Bhardwaj and Mehta report no relevant financial disclosures.

In this episode, Atul C. Mehta, MB, BS, discusses his path to become a physician, his early struggles once he arrived in the United States and some of the changes he’s witnessed in how bronchoscopies are performed. <ul> <li>Intro :00</li> <li>About Mehta :23</li> <li>The interview 1:25</li> <li>In your own words … how did you get into medicine? 2:14</li> <li>Can you share a little bit about your initial struggle coming to the United States? 7:10</li> <li>Is your altruistic nature as a physician and mentor a result of coming from a humble background when you started your medical career? 13:14</li> <li>You still work 15, 16 hours a day for almost 50 years … How do you have the energy to do that? 17:10</li> <li>What have you seen that has changed from when you saw your first flexible bronchoscopy to now? 20:07</li> <li>How do you find time for family with all you do and how do you do justice with that? 24:53</li> <li>How do you prevent burnout in this demanding career? 28:21</li> <li>You have worked in different countries … how did those things happen? 33:15</li> <li>How old were your kids during your time working in India and Abu Dhabi? 37:01</li> <li>I know you have family in Bollywood … are you a big fan of Bollywood? 39:42</li> <li>Do you have a moment to share any failures that you felt were really important to learn from? 40:30</li> <li>Do you have very fond memories from your childhood, or any med school quotes that you think of? 43:37</li> <li>Is there anything else you’d like to share? 45:40</li> <li>Thanks for listening! 45:49</li> </ul> Atul C. Mehta, MB, BS, is professor of medicine, Lerner College of Medicine; endowed chair in lung transplantation, Cleveland Clinic and founder and president of the American Association of Bronchoscopy. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter <a href="https://twitter.com/HealioPulm" rel="nofollow" target="_blank">@HealioPulm</a> <a href="https://twitter.com/abhi_bhardwaj99" rel="nofollow" target="_blank">@abhi_bhardwaj99</a>. Disclosures: Bhardwaj and Mehta report no relevant financial disclosures.

Medical Education and Leadership, Part 5: Foreign Medical Graduates in Leadership with Atul C. Mehta, MD

A podcast providing clinical pearls and insight from experts in the field, plus the top headlines in pulmonary and critical care medicine.

This week, symptoms after first mRNA vaccine dose linked to previous SARS-CoV-2 infection; US to offer booster shots to fully vaccinated Americans starting Sept. 20; CBD eases emotional exhaustion, burnout symptoms in study of frontline health care workers; and more. Read the full coverage here:  Symptoms after first mRNA vaccine dose linked to previous SARS-CoV-2 infection  US to offer booster shots to fully vaccinated Americans starting Sept. 20  CBD eases emotional exhaustion, burnout symptoms in study of frontline health care workers  Vegan diet provides most health benefits among plant-based eating patterns  Dexamethasone may be ‘underused’ among critically ill patients with COVID-19 References:  Debes AK, et al. JAMA Intern Med. 2021;doi:10.1001/jamainternmed.2021.4580. Press Conference  Crippa JAS, et al. JAMA Netw Open. 2021;doi:10.1001/jamanetworkopen.2021.20603. Jardine M, et al. D-18. Presented at: ADCES21; Aug. 12-15, 2021 (virtual meeting). Mehta HB, et al. 2021;doi: Ann Intern Med. doi:10.7326/M21-0857.

This week, symptoms after first mRNA vaccine dose linked to previous SARS-CoV-2 infection; US to offer booster shots to fully vaccinated Americans starting Sept. 20; CBD eases emotional exhaustion, burnout symptoms in study of frontline health care workers; and more. Read the full coverage here: <a href="https://www.healio.com/news/primary-care/20210816/symptoms-after-first-mrna-vaccine-dose-linked-to-previous-sarscov2-infection" rel="nofollow" target="_blank"> Symptoms after first mRNA vaccine dose linked to previous SARS-CoV-2 infection</a> <a href="https://www.healio.com/news/infectious-disease/20210818/us-to-offer-booster-shots-to-fully-vaccinated-americans-starting-sept-20" rel="nofollow" target="_blank"> US to offer booster shots to fully vaccinated Americans starting Sept. 20</a> <a href="https://www.healio.com/news/psychiatry/20210816/cbd-eases-emotional-exhaustion-burnout-symptoms-in-study-of-frontline-health-care-workers" rel="nofollow" target="_blank"> CBD eases emotional exhaustion, burnout symptoms in study of frontline health care workers</a> <a href="https://www.healio.com/news/endocrinology/20210818/vegan-diet-provides-most-health-benefits-among-plantbased-eating-patterns" rel="nofollow" target="_blank"> Vegan diet provides most health benefits among plant-based eating patterns</a> <a href="https://www.healio.com/news/primary-care/20210816/dexamethasone-may-be-underused-among-critically-ill-patients-with-covid19" rel="nofollow" target="_blank"> Dexamethasone may be ‘underused’ among critically ill patients with COVID-19</a> References: <a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2782821" rel="nofollow" target="_blank"> Debes AK, et al. JAMA Intern Med. 2021;doi:10.1001/jamainternmed.2021.4580.</a> Press Conference <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2782994" rel="nofollow" target="_blank"> Crippa JAS, et al. JAMA Netw Open. 2021;doi:10.1001/jamanetworkopen.2021.20603.</a> Jardine M, et al. D-18. Presented at: ADCES21; Aug. 12-15, 2021 (virtual meeting). <a href="https://www.acpjournals.org/doi/10.7326/M21-0857" rel="nofollow" target="_blank">Mehta HB, et al. 2021;doi: Ann Intern Med. doi:10.7326/M21-0857.</a>

This Week's Headlines: August 23, 2021

This week, the FDA approves single-use bronchoscopes; a study finds the Moderna COVID-19 vaccine is safe and effective in adolescents; CMS nixes the most-favored nation pricing model for Medicare Part B; and more. Read the full coverage here:  Single-use bronchoscope receives FDA clearance  Moderna COVID-19 vaccine safe, efficacious in adolescents  Adoption of newer antifibrotic medications for IPF low in US in everyday practice: Study  FDA allows third dose of COVID-19 vaccine for immunocompromised patients  CMS nixes 'most-favored nation' pricing model for Medicare Part B References: Ali K, et al. N Engl J Med. 2021;doi:10.1057/NEJMoa2109522.  CMS proposed rule.  Dempsey TM, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202007-901OC.  Press Release.  Press Release.

This week, the FDA approves single-use bronchoscopes; a study finds the Moderna COVID-19 vaccine is safe and effective in adolescents; CMS nixes the most-favored nation pricing model for Medicare Part B; and more. Read the full coverage here: <a href="https://www.healio.com/news/pulmonology/20210813/singleuse-bronchoscope-receives-fda-clearance" rel="nofollow" target="_blank"> Single-use bronchoscope receives FDA clearance</a> <a href="https://www.healio.com/news/primary-care/20210812/moderna-covid19-vaccine-safe-efficacious-in-adolescents" rel="nofollow" target="_blank"> Moderna COVID-19 vaccine safe, efficacious in adolescents</a> <a href="https://www.healio.com/news/pulmonology/20210813/adoption-of-newer-antifibrotic-medications-for-ipf-low-in-us-in-everyday-practice-study" rel="nofollow" target="_blank"> Adoption of newer antifibrotic medications for IPF low in US in everyday practice: Study</a> <a href="https://www.healio.com/news/infectious-disease/20210813/fda-allows-third-dose-of-covid19-vaccine-for-immunocompromised-patients" rel="nofollow" target="_blank"> FDA allows third dose of COVID-19 vaccine for immunocompromised patients</a> <a href="https://www.healio.com/news/rheumatology/20210810/cms-nixes-mostfavored-nation-pricing-model-for-medicare-part-b" rel="nofollow" target="_blank"> CMS nixes 'most-favored nation' pricing model for Medicare Part B</a> References: <a href="http://www.nejm.org/doi/full/10.1056/NEJMoa2109522" rel="nofollow" target="_blank">Ali K, et al. N Engl J Med. 2021;doi:10.1057/NEJMoa2109522.</a> <a href="https://www.federalregister.gov/documents/2021/08/10/2021-16886/most-favored-nation-mfn-model" rel="nofollow" target="_blank"> CMS proposed rule.</a> <a href="https://www.atsjournals.org/doi/full/10.1513/AnnalsATS.202007-901OC" rel="nofollow" target="_blank"> Dempsey TM, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202007-901OC.</a> <a href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-certain-immunocompromised" rel="nofollow" target="_blank"> Press Release.</a> <a href="https://news.bostonscientific.com/2021-08-10-Boston-Scientific-Receives-FDA-Clearance-for-EXALT-TM-Model-B-Single-Use-Bronchoscope" rel="nofollow" target="_blank"> Press Release.</a>

This Week's Headlines: August 16, 2021

This week, the CDC confirms a fatal case of melioidosis in Georgia; Moderna says its vaccine is 93% effective at 6 months; a survey shows patients prefer that physicians wear white coats; and more. Read the full coverage here:  CDC confirms fatal case of melioidosis in Georgia, links it to previous US cases  Moderna COVID-19 vaccine 93% effective, ‘durable’ at 6 months, company says  Casual attire is becoming more popular among physicians, but patients prefer white coats  Modified Mediterranean-ketogenic diet may reduce cognitive decline  Coexistence of bronchiectasis with asthma, chronic rhinosinusitis common References: Kawas MI, et al. Modified Mediterranean Ketogenic diet resolves default node network connectivity differences between adults with normal and impaired cognition: A pilot study. Presented at: Alzheimer’s Association International Conference; July 26-30, 2021 (virtual meeting). Press Release.  Press Release.  Sheng H, et al. BMC Pulm Med. 2021;doi:10.1186/s12890-021-01575-7.  Xun H, et al. JAMA Netw Open. 2021;doi:10.1001/jamanetworkopen.2021.17779.

This week, the CDC confirms a fatal case of melioidosis in Georgia; Moderna says its vaccine is 93% effective at 6 months; a survey shows patients prefer that physicians wear white coats; and more. Read the full coverage here: <a href="https://www.healio.com/news/infectious-disease/20210809/cdc-confirms-fatal-case-of-melioidosis-in-georgia-links-it-to-previous-us-cases" rel="nofollow" target="_blank"> CDC confirms fatal case of melioidosis in Georgia, links it to previous US cases</a> <a href="https://www.healio.com/news/primary-care/20210805/moderna-covid19-vaccine-93-effective-durable-at-6-months-company-says" rel="nofollow" target="_blank"> Moderna COVID-19 vaccine 93% effective, ‘durable’ at 6 months, company says</a> <a href="https://www.healio.com/news/primary-care/20210806/casual-attire-is-becoming-more-popular-among-physicians-but-patients-prefer-white-coats" rel="nofollow" target="_blank"> Casual attire is becoming more popular among physicians, but patients prefer white coats</a> <a href="https://www.healio.com/news/primary-care/20210803/modified-mediterraneanketogenic-diet-may-reduce-cognitive-decline" rel="nofollow" target="_blank"> Modified Mediterranean-ketogenic diet may reduce cognitive decline</a> <a href="https://www.healio.com/news/pulmonology/20210806/coexistence-of-bronchiectasis-with-asthma-chronic-rhinosinusitis-common" rel="nofollow" target="_blank"> Coexistence of bronchiectasis with asthma, chronic rhinosinusitis common</a> References: Kawas MI, et al. Modified Mediterranean Ketogenic diet resolves default node network connectivity differences between adults with normal and impaired cognition: A pilot study. Presented at: Alzheimer’s Association International Conference; July 26-30, 2021 (virtual meeting). Press Release. <a href="https://investors.modernatx.com/news-releases/news-release-details/moderna-reports-second-quarter-fiscal-year-2021-financial" rel="nofollow" target="_blank"> Press Release</a>. <a href="https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-021-01575-7" rel="nofollow" target="_blank"> Sheng H, et al. BMC Pulm Med. 2021;doi:10.1186/s12890-021-01575-7.</a> <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2782564" rel="nofollow" target="_blank"> Xun H, et al. JAMA Netw Open. 2021;doi:10.1001/jamanetworkopen.2021.17779.</a>

This Week's Headlines: August 9, 2021

This week, Pfizer says a third dose of the vaccine boosts protection, even against the delta variant; US News and World Report ranks Mayo Clinic number 1 for pulmonology and lung surgery; the FDA approves IV selexipag for adults with PAH; and more. Read the full coverage here:  Pfizer says third dose of vaccine boosts protection, including against delta variant  CDC alters mask guidance, says even vaccinated Americans need them in some places  Mayo Clinic ranked No. 1 hospital in US for pulmonology, lung surgery  FDA approves selexipag for IV use in adults with PAH  FDA approves Saphnelo, first new lupus treatment since 2011 References:  AstraZeneca press release.  Lupus Research Alliance press release. Pfizer. Second quarter 2021 earnings teleconference. July 28, 2021.  https://s21.q4cdn.com/317678438/files/doc_financials/2021/q2/Q2-2021-Earnings-Charts-FINAL.pdf. Accessed on July 28, 2021. Press Conference.  Press Release. U.S. News &amp; World Report.

This week, Pfizer says a third dose of the vaccine boosts protection, even against the delta variant; US News and World Report ranks Mayo Clinic number 1 for pulmonology and lung surgery; the FDA approves IV selexipag for adults with PAH; and more. Read the full coverage here: <a href="https://www.healio.com/news/infectious-disease/20210728/pfizer-says-third-dose-of-vaccine-boosts-protection-including-against-delta-variant" rel="nofollow" target="_blank"> Pfizer says third dose of vaccine boosts protection, including against delta variant</a> <a href="https://www.healio.com/news/primary-care/20210727/cdc-alters-mask-guidance-says-even-vaccinated-americans-need-them-in-some-places" rel="nofollow" target="_blank"> CDC alters mask guidance, says even vaccinated Americans need them in some places</a> <a href="https://www.healio.com/news/pulmonology/20210727/mayo-clinic-ranked-no-1-hospital-in-us-for-pulmonology-lung-surgery" rel="nofollow" target="_blank"> Mayo Clinic ranked No. 1 hospital in US for pulmonology, lung surgery</a> <a href="https://www.healio.com/news/pulmonology/20210730/fda-approves-selexipag-for-iv-use-in-adults-with-pah" rel="nofollow" target="_blank"> FDA approves selexipag for IV use in adults with PAH</a> <a href="https://www.healio.com/news/rheumatology/20210802/fda-approves-saphnelo-first-new-lupus-treatment-since-2011" rel="nofollow" target="_blank"> FDA approves Saphnelo, first new lupus treatment since 2011</a> References: <a href="https://www.astrazeneca.com/media-centre/press-releases/2021/saphnelo-approved-in-the-us-for-sle.html" rel="nofollow" target="_blank"> AstraZeneca press release.</a> <a href="https://www.lupusresearch.org/lupus-research-alliance-applauds-u-s-fda-approval-of-astrazenecas-anifrolumab-fnia-saphnelo-for-systemic-lupus-erythematosus-sle/" rel="nofollow" target="_blank"> Lupus Research Alliance press release.</a> Pfizer. Second quarter 2021 earnings teleconference. July 28, 2021. <a href="https://s21.q4cdn.com/317678438/files/doc_financials/2021/q2/Q2-2021-Earnings-Charts-FINAL.pdf" rel="nofollow" target="_blank"> https://s21.q4cdn.com/317678438/files/doc_financials/2021/q2/Q2-2021-Earnings-Charts-FINAL.pdf</a>. Accessed on July 28, 2021. Press Conference. <a href="https://www.prnewswire.com/news-releases/uptravi-selexipag-receives-fda-approval-for-intravenous-use-in-adult-patients-with-pulmonary-arterial-hypertension-pah-301345104.html" rel="nofollow" target="_blank"> Press Release.</a> <a href="https://health.usnews.com/best-hospitals/rankings?src=usn_pr" rel="nofollow" target="_blank">U.S. News &amp; World Report.</a>

This Week's Headlines: August 2, 2021

This week, CHEST issues guidelines for low-dose CT screening for lung cancer; severe COVID-19 survivors experience pulmonary impairment; the FDA approves Prograf to prevent lung transplant rejection; and more. Read the full coverage here:  CHEST issues new guideline on benefits, harms, use of low-dose CT screening for lung cancer  Pulmonary impairment ‘highly prevalent’ in severe COVID-19 survivors following discharge  FDA approves Prograf to prevent organ rejection in lung transplant recipients  In omega-3 fatty acid trials, EPA alone yields greater CV risk reduction vs. EPA plus DHA  Benefit of full-dose heparin for patients with COVID-19 warrants ‘new standard of care’ References:  González J, et al. Chest. 2021;doi:10.1016/j.chest.2021.02.062.  Khan SU, et al. eClinical Medicine. 2021;doi:10.1016/j.eclinm.2021.100997. Mazzone PJ, et al. Chest. 2021;doi:10.1016/j.chest.2021.06.063.  Press Release. Sholzberg M, et al. medRxiv. 2021;doi:10.1101/2021.07.08.21259351.

This week, CHEST issues guidelines for low-dose CT screening for lung cancer; severe COVID-19 survivors experience pulmonary impairment; the FDA approves Prograf to prevent lung transplant rejection; and more. Read the full coverage here: <a href="https://www.healio.com/news/pulmonology/20210721/chest-issues-new-guideline-on-benefits-harms-use-of-lowdose-ct-screening-for-lung-cancer" rel="nofollow" target="_blank"> CHEST issues new guideline on benefits, harms, use of low-dose CT screening for lung cancer</a> <a href="https://www.healio.com/news/pulmonology/20210723/pulmonary-impairment-highly-prevalent-in-severe-covid19-survivors-following-discharge" rel="nofollow" target="_blank"> Pulmonary impairment ‘highly prevalent’ in severe COVID-19 survivors following discharge</a> <a href="https://www.healio.com/news/pulmonology/20210722/fda-approves-prograf-to-prevent-organ-rejection-in-lung-transplant-recipients" rel="nofollow" target="_blank"> FDA approves Prograf to prevent organ rejection in lung transplant recipients</a> <a href="https://www.healio.com/news/cardiology/20210722/in-omega3-fatty-acid-trials-epa-alone-yields-greater-cv-risk-reduction-vs-epa-plus-dha" rel="nofollow" target="_blank"> In omega-3 fatty acid trials, EPA alone yields greater CV risk reduction vs. EPA plus DHA</a> <a href="https://www.healio.com/news/hematology-oncology/20210720/benefit-of-fulldose-heparin-for-patients-with-covid19-warrants-new-standard-of-care" rel="nofollow" target="_blank"> Benefit of full-dose heparin for patients with COVID-19 warrants ‘new standard of care’</a> References: <a href="https://journal.chestnet.org/article/S0012-3692(21)00464-5/fulltext" rel="nofollow" target="_blank"> González J, et al. Chest. 2021;doi:10.1016/j.chest.2021.02.062.</a> <a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00277-7/fulltext" rel="nofollow" target="_blank"> Khan SU, et al. eClinical Medicine. 2021;doi:10.1016/j.eclinm.2021.100997.</a> <a href="https://journal.chestnet.org/article/S0012-3692(21)01307-6/pdf" rel="nofollow" target="_blank">Mazzone PJ, et al. Chest. 2021;doi:10.1016/j.chest.2021.06.063.</a> <a href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-approves-new-use-transplant-drug-based-real-world-evidence" rel="nofollow" target="_blank"> Press Release.</a> <a href="https://www.medrxiv.org/content/10.1101/2021.07.08.21259351v3" rel="nofollow" target="_blank">Sholzberg M, et al. medRxiv. 2021;doi:10.1101/2021.07.08.21259351.</a>

This Week's Headlines: July 26, 2021

In this episode, the original “zentensivisit” Matt Siuba, DO, sits down with me to discuss the concept of zentensivism, tips for social media, and much more. Don’t miss his top critical care papers every fellow should know.  Intro :15 About Siuba :41 The interview 1:30 Tell me a bit about yourself in your own words 1:54 Did you always know you wanted to be a doctor? 3:59 The whole concept of zentensivism … how did it start? 6:30 When did you get involved with Twitter? 11:26 Do you have advice for people who want to minimize negative attraction on social media? 13:50 How do you manage time? 16:44 Has this time management strategy been something you have been doing for very long? 19:48 Have you ever experienced imposter syndrome? 21:41 Do you have some examples from your med school or residency days where you felt like you were too hard on yourself? 25:16 What makes you happy? What fun things do you like to do? 27:44 Any examples of things in your professional life that you were disappointed in or wished could have gone differently? 32:35 Are there strategies to minimize and delay burnout and have more resilience? 37:06 Do you have any specific advice for the listeners apart from the three points of ‘sleep more,’ ‘less is more’ and ‘be more curious?’ 42:51 Have you noticed the difference in how foreign-born DOs go through a much harder time? 44:20 Can you share with me some of the important papers that every critical care fellow needs to know? 47:03 Thanks for listening 50:47  Matt Siuba, DO, is an intensivist at the Cleveland Clinic. His interests include circulatory shock as well as severe forms of respiratory failure, especially acute respiratory distress syndrome. He is invested in zentensivism: minimally invasive, maximally attentive medical care. Siuba is enrolled in the M.S. in Clinical Research program at Case Western Reserve University. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99. Dr. Siuba can be reached on Twitter  @msiuba. Disclosures: Bhardwaj and Siuba report no relevant financial disclosures.

In this episode, the original “zentensivisit” Matt Siuba, DO, sits down with me to discuss the concept of zentensivism, tips for social media, and much more. Don’t miss his top critical care papers every fellow should know. <ul> <li>Intro :15</li> <li>About Siuba :41</li> <li>The interview 1:30</li> <li>Tell me a bit about yourself in your own words 1:54</li> <li>Did you always know you wanted to be a doctor? 3:59</li> <li>The whole concept of zentensivism … how did it start? 6:30</li> <li>When did you get involved with Twitter? 11:26</li> <li>Do you have advice for people who want to minimize negative attraction on social media? 13:50</li> <li>How do you manage time? 16:44</li> <li>Has this time management strategy been something you have been doing for very long? 19:48</li> <li>Have you ever experienced imposter syndrome? 21:41</li> <li>Do you have some examples from your med school or residency days where you felt like you were too hard on yourself? 25:16</li> <li>What makes you happy? What fun things do you like to do? 27:44</li> <li>Any examples of things in your professional life that you were disappointed in or wished could have gone differently? 32:35</li> <li>Are there strategies to minimize and delay burnout and have more resilience? 37:06</li> <li>Do you have any specific advice for the listeners apart from the three points of ‘sleep more,’ ‘less is more’ and ‘be more curious?’ 42:51</li> <li>Have you noticed the difference in how foreign-born DOs go through a much harder time? 44:20</li> <li>Can you share with me some of the important papers that every critical care fellow needs to know? 47:03</li> <li>Thanks for listening 50:47</li> </ul> Matt Siuba, DO, is an intensivist at the Cleveland Clinic. His interests include circulatory shock as well as severe forms of respiratory failure, especially acute respiratory distress syndrome. He is invested in zentensivism: minimally invasive, maximally attentive medical care. Siuba is enrolled in the M.S. in Clinical Research program at Case Western Reserve University. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter <a href="https://twitter.com/HealioPulm" rel="nofollow" target="_blank">@HealioPulm</a> <a href="https://twitter.com/abhi_bhardwaj99" rel="nofollow" target="_blank">@abhi_bhardwaj99</a>. Dr. Siuba can be reached on Twitter <a href="https://twitter.com/msiuba?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor" rel="nofollow" target="_blank"> @msiuba</a>. Disclosures: Bhardwaj and Siuba report no relevant financial disclosures.

The Fine Art of Critical Care Medicine, Part 1: The Original Zentensivist, Matt Siuba, DO

This week, surging caseloads are linked to nearly one quarter of US COVID-19 deaths; booster doses may not be necessary for the Pfizer vaccine; the FDA calls for an investigation into the recent Alzheimer’s drug approval; cancer death rates continue to decline; and frailty is tied to longer mechanical ventilation. Read the full coverage here:  23% of COVID-19 deaths at US hospitals linked to surging caseloads  CDC, FDA say booster doses not needed as Pfizer eyes authorization  FDA calls for a federal investigation into Aduhelm approval  Declines in cancer death rates continue, but not for all common types  Frailty tied to longer mechanical ventilation, identifies those less likely to be liberated References: BioNTech. Pfizer and BioNTech provide update on booster program in light of the delta-variant. https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-provide-update-booster-program-light-delta. Accessed on July 9, 2021. HHS. Joint CDC and FDA statement on vaccine boosters. https://www.hhs.gov/about/news/2021/07/08/joint-cdc-and-fda-statement-vaccine-boosters.html. Accessed on July 9, 2021.  Islami F, et al. J Natl Cancer Inst. 2021;doi:10.1093/jnci/djab131. Kadri SS, et al. Ann Intern Med. 2021;doi:10.7326/M21-1213.  Okahara S, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202102-178OC. STAT. FDA calls for federal investigation into its controversial Alzheimer’s drug approval. Available at:  https://www.statnews.com/2021/07/09/fda-investigation-alzheimers-drug-approval/?utm_source=STAT+Newsletters&amp;utm_campaign=972fd2c048-breaking_COPY_01&amp;utm_medium=email&amp;utm_term=0_8cab1d7961-972fd2c048-151965521. Accessed July 9, 2021.

This week, surging caseloads are linked to nearly one quarter of US COVID-19 deaths; booster doses may not be necessary for the Pfizer vaccine; the FDA calls for an investigation into the recent Alzheimer’s drug approval; cancer death rates continue to decline; and frailty is tied to longer mechanical ventilation. Read the full coverage here: <a href="https://www.healio.com/news/primary-care/20210709/23-of-covid19-deaths-at-us-hospitals-linked-to-surging-caseloads" rel="nofollow" target="_blank"> 23% of COVID-19 deaths at US hospitals linked to surging caseloads</a> <a href="https://www.healio.com/news/infectious-disease/20210709/cdc-fda-say-booster-doses-not-needed-as-pfizer-eyes-authorization" rel="nofollow" target="_blank"> CDC, FDA say booster doses not needed as Pfizer eyes authorization</a> <a href="https://www.healio.com/news/neurology/20210709/fda-calls-for-a-federal-investigation-into-aduhelm-approval" rel="nofollow" target="_blank"> FDA calls for a federal investigation into Aduhelm approval</a> <a href="https://www.healio.com/news/hematology-oncology/20210708/declines-in-cancer-death-rates-continue-but-not-for-all-common-types" rel="nofollow" target="_blank"> Declines in cancer death rates continue, but not for all common types</a> <a href="https://www.healio.com/news/pulmonology/20210708/frailty-tied-to-longer-mechanical-ventilation-identifies-those-less-likely-to-be-liberated" rel="nofollow" target="_blank"> Frailty tied to longer mechanical ventilation, identifies those less likely to be liberated</a> References: BioNTech. Pfizer and BioNTech provide update on booster program in light of the delta-variant. <a href="https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-provide-update-booster-program-light-delta" rel="nofollow" target="_blank">https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-provide-update-booster-program-light-delta</a>. Accessed on July 9, 2021. HHS. Joint CDC and FDA statement on vaccine boosters. <a href="https://www.hhs.gov/about/news/2021/07/08/joint-cdc-and-fda-statement-vaccine-boosters.html" rel="nofollow" target="_blank">https://www.hhs.gov/about/news/2021/07/08/joint-cdc-and-fda-statement-vaccine-boosters.html</a>. Accessed on July 9, 2021. <a href="https://academic.oup.com/jnci/advance-article-abstract/doi/10.1093/jnci/djab131/6312532?redirectedFrom=fulltext" rel="nofollow" target="_blank"> Islami F, et al. J Natl Cancer Inst. 2021;doi:10.1093/jnci/djab131</a>. <a href="https://www.acpjournals.org/doi/full/10.7326/M21-1213" rel="nofollow" target="_blank">Kadri SS, et al. Ann Intern Med. 2021;doi:10.7326/M21-1213.</a> <a href="https://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.202102-178OC" rel="nofollow" target="_blank"> Okahara S, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202102-178OC</a>. STAT. FDA calls for federal investigation into its controversial Alzheimer’s drug approval. Available at: <a href="https://www.statnews.com/2021/07/09/fda-investigation-alzheimers-drug-approval/?utm_source=STAT+Newsletters&amp;utm_campaign=972fd2c048-breaking_COPY_01&amp;utm_medium=email&amp;utm_term=0_8cab1d7961-972fd2c048-151965521" rel="nofollow" target="_blank"> https://www.statnews.com/2021/07/09/fda-investigation-alzheimers-drug-approval/?utm_source=STAT+Newsletters&amp;utm_campaign=972fd2c048-breaking_COPY_01&amp;utm_medium=email&amp;utm_term=0_8cab1d7961-972fd2c048-151965521</a>. Accessed July 9, 2021.

This Week's Headlines: July 12, 2021

This week, low-dose azithromycin did not improve cough in patients with IPF; tele-pulmonary rehab may lower barriers to care; the J&amp;J vaccine provides 8-month protection from the delta variant; a daily ECMO liberation protocol was found to be safe and feasible; and portable air cleaners could reduce exposure to SARS-CoV-2 aerosols. Read the full coverage here:  Study does not support low-dose azithromycin to treat chronic cough in IPF  Telehealth pulmonary rehabilitation program for COPD accessible, feasible, safe  J&amp;J vaccine protects against delta variant for at least 8 months, studies find  ECMO-free protocol feasible, may aid earlier identification of patients for decannulation  Portable air cleaners could reduce exposure to SARS-CoV-2 aerosols, study finds References:  Alwakeel AJ, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202006-638OC. Gannon WD, et al. Chest. 2021;doi:10.1016/j.chest.2021.05.066.  Guler SA, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202103-266OC.  Lindsley WG, et al. MMWR Morb Mortal Wkly Rep. 2021;doi:10.15585/mmwr.mm7027e1.

This week, low-dose azithromycin did not improve cough in patients with IPF; tele-pulmonary rehab may lower barriers to care; the J&amp;J vaccine provides 8-month protection from the delta variant; a daily ECMO liberation protocol was found to be safe and feasible; and portable air cleaners could reduce exposure to SARS-CoV-2 aerosols. Read the full coverage here: <a href="https://www.healio.com/news/pulmonology/20210628/study-does-not-support-lowdose-azithromycin-to-treat-chronic-cough-in-ipf" rel="nofollow" target="_blank"> Study does not support low-dose azithromycin to treat chronic cough in IPF</a> <a href="https://www.healio.com/news/pulmonology/20210702/telehealth-pulmonary-rehabilitation-program-for-copd-accessible-feasible-safe" rel="nofollow" target="_blank"> Telehealth pulmonary rehabilitation program for COPD accessible, feasible, safe</a> <a href="https://www.healio.com/news/infectious-disease/20210702/jj-vaccine-protects-against-delta-variant-for-at-least-8-months-studies-find" rel="nofollow" target="_blank"> J&amp;J vaccine protects against delta variant for at least 8 months, studies find</a> <a href="https://www.healio.com/news/pulmonology/20210625/ecmofree-protocol-feasible-may-aid-earlier-identification-of-patients-for-decannulation" rel="nofollow" target="_blank"> ECMO-free protocol feasible, may aid earlier identification of patients for decannulation</a> <a href="https://www.healio.com/news/20210702/portable-air-cleaners-could-reduce-exposure-to-sarscov2-aerosols-study-finds" rel="nofollow" target="_blank"> Portable air cleaners could reduce exposure to SARS-CoV-2 aerosols, study finds</a> References: <a href="https://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.202006-638OC" rel="nofollow" target="_blank"> Alwakeel AJ, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202006-638OC.</a> <a href="https://journal.chestnet.org/article/S0012-3692(21)01115-6/pdf" rel="nofollow" target="_blank">Gannon WD, et al. Chest. 2021;doi:10.1016/j.chest.2021.05.066.</a> <a href="https://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.202103-266OC" rel="nofollow" target="_blank"> Guler SA, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202103-266OC.</a> <a href="https://www.cdc.gov/mmwr/volumes/70/wr/mm7027e1.htm?s_cid=mm7027e1" rel="nofollow" target="_blank"> Lindsley WG, et al. MMWR Morb Mortal Wkly Rep. 2021;doi:10.15585/mmwr.mm7027e1.</a>

This Week's Headlines: July 5, 2021

This week, the FDA issues an EUA for tocilizumab in COVID-19; an electronic tool detects ovarian and pancreatic cancers; the delta variant accounts for 20% of new COVID-19 cases; researchers uncover variables linked with COVID-19 fatalities; and the ACIP recommends the dengue vaccine for children in endemic areas. Read the full coverage here:  FDA issues EUA for tocilizumab to treat patients hospitalized with COVID-19  ‘Electronic nose’ accurately detects ovarian, pancreatic cancers  Fauci: 20% of new COVID-19 cases are from delta variant  Researchers identify variables associated with COVID-19 fatalities during first wave  ACIP unanimously recommends dengue vaccine for children aged 9 to 16 years References: CDC. Advisory Committee on Immunization Practices. https://www.cdc.gov/vaccines/acip/index.html. Accessed June 24, 2021.  FDA press release.  Genentech press release. Johnson ATC, et al. Abstract 9004. Presented at: ASCO Annual Meeting (virtual meeting); June 4-8, 2021. Millar JA, et al. Risk factors for increased COVID-19 case-fatality in the United States: A county-level analysis during the first wave. Presented at World Microbe Forum; June 20-24, 2021 (virtual meeting).

This week, the FDA issues an EUA for tocilizumab in COVID-19; an electronic tool detects ovarian and pancreatic cancers; the delta variant accounts for 20% of new COVID-19 cases; researchers uncover variables linked with COVID-19 fatalities; and the ACIP recommends the dengue vaccine for children in endemic areas. Read the full coverage here: <a href="https://www.healio.com/news/rheumatology/20210625/fda-issues-eua-for-tocilizumab-to-treat-patients-hospitalized-with-covid19" rel="nofollow" target="_blank"> FDA issues EUA for tocilizumab to treat patients hospitalized with COVID-19</a> <a href="https://www.healio.com/news/hematology-oncology/20210622/electronic-nose-accurately-detects-ovarian-pancreatic-cancers" rel="nofollow" target="_blank"> ‘Electronic nose’ accurately detects ovarian, pancreatic cancers</a> <a href="https://www.healio.com/news/primary-care/20210623/fauci-20-of-new-covid19-cases-are-from-delta-variant" rel="nofollow" target="_blank"> Fauci: 20% of new COVID-19 cases are from delta variant</a> <a href="https://www.healio.com/news/infectious-disease/20210622/researchers-identify-variables-associated-with-covid19-fatalities-during-first-wave" rel="nofollow" target="_blank"> Researchers identify variables associated with COVID-19 fatalities during first wave</a> <a href="https://www.healio.com/news/primary-care/20210624/acip-recommends-dengue-vaccine-for-children-aged-9-to-16-years" rel="nofollow" target="_blank"> ACIP unanimously recommends dengue vaccine for children aged 9 to 16 years</a> References: CDC. Advisory Committee on Immunization Practices. <a href="https://www.cdc.gov/vaccines/acip/index.html" rel="nofollow" target="_blank">https://www.cdc.gov/vaccines/acip/index.html</a>. Accessed June 24, 2021. <a href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-treatment-covid-19" rel="nofollow" target="_blank"> FDA press release.</a> <a href="https://www.gene.com/media/press-releases/14917/2021-06-24/genentechs-actemra-receives-fda-emergenc" rel="nofollow" target="_blank"> Genentech press release.</a> Johnson ATC, et al. Abstract 9004. Presented at: ASCO Annual Meeting (virtual meeting); June 4-8, 2021. Millar JA, et al. Risk factors for increased COVID-19 case-fatality in the United States: A county-level analysis during the first wave. Presented at World Microbe Forum; June 20-24, 2021 (virtual meeting).

This Week's Headlines: June 28, 2021

James Stoller, MD, MS, is chair of the Education Institute at Cleveland Clinic. His love for patient care and passion for medical education is palpable. In this episode we discuss burnout, imposter syndrome and thought leadership.  Intro :34 About Stoller :38 The interview 2:03 Tell me about yourself 2:04   Do you remember making an active effort to create such a positive training environment here at Cleveland Clinic? 3:26 Becoming a doctor is intrinsically arduous 6:11 Did you plan to be in the role you’re in today? 6:56 How do you overcome internal doubt, and can leadership traits be cultivated? 13:34 Do you agree there’s a role for leadership curriculum in medical school training? 21:07 How have you managed to attend every one of your son’s NFL games? 23:14 Lessons from the pandemic 26:55 As a kid, were you always this disciplined? 29:17 Are there any memories from your training that stand out? 34:56 What are some of the happiest memories from your childhood? 38:52 Is there any other way that you double up resilience in your trainees so that they can continue and have a long, fulfilling career? 40:50 What are some of the challenges you face on a daily basis? 41:12 What advice would you give your younger self? 47:11 Do you have advice for the listeners? 48:18 Thank you, Dr. Stoller 50:57  James Stoller, MD, MS, is executive director of physician leadership development and chair of the Education Institute at Cleveland Clinic. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter @HealioPulm @abhi_bhardwaj99. Disclosures: Bhardwaj and Stoller report no relevant financial disclosures.

James Stoller, MD, MS, is chair of the Education Institute at Cleveland Clinic. His love for patient care and passion for medical education is palpable. In this episode we discuss burnout, imposter syndrome and thought leadership. <ul> <li>Intro :34</li> <li>About Stoller :38</li> <li>The interview 2:03</li> <li>Tell me about yourself 2:04</li> </ul> <ul> <li>Do you remember making an active effort to create such a positive training environment here at Cleveland Clinic? 3:26</li> <li>Becoming a doctor is intrinsically arduous 6:11</li> <li>Did you plan to be in the role you’re in today? 6:56</li> <li>How do you overcome internal doubt, and can leadership traits be cultivated? 13:34</li> <li>Do you agree there’s a role for leadership curriculum in medical school training? 21:07</li> <li>How have you managed to attend every one of your son’s NFL games? 23:14</li> <li>Lessons from the pandemic 26:55</li> <li>As a kid, were you always this disciplined? 29:17</li> <li>Are there any memories from your training that stand out? 34:56</li> <li>What are some of the happiest memories from your childhood? 38:52</li> <li>Is there any other way that you double up resilience in your trainees so that they can continue and have a long, fulfilling career? 40:50</li> <li>What are some of the challenges you face on a daily basis? 41:12</li> <li>What advice would you give your younger self? 47:11</li> <li>Do you have advice for the listeners? 48:18</li> <li>Thank you, Dr. Stoller 50:57</li> </ul> James Stoller, MD, MS, is executive director of physician leadership development and chair of the Education Institute at Cleveland Clinic. We’d love to hear from you! Send your comments/questions to Dr. Bhardwaj at podcast@healio.com. Follow us on Twitter <a href="https://twitter.com/HealioPulm" rel="nofollow" target="_blank">@HealioPulm</a> <a href="https://twitter.com/abhi_bhardwaj99" rel="nofollow" target="_blank">@abhi_bhardwaj99</a>. Disclosures: Bhardwaj and Stoller report no relevant financial disclosures.

Medical Education and Leadership, Part 4: James Stoller, MD

Vital Capacity

The best podcast episodes on romantic relationships. Episodes talk about the 5 love languages, intimacy, and the taboo topics of sexual desires and infidelity. This topic is a deep dive into the science and complexities that face us in our relationships with others. Add episodes you're interested into your queue below!

Best Episodes on Relationships & Love

What is this?
1 quote, 3 ideas & 1 question from a carefully curated podcast episode.
Every Monday & Wednesday.

Want a 3rd insight and episode every week? Email me at curation@owltail.com.